These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Mode of action of mosquitocidal Bacillus thuringiensis toxins. Soberón M; Fernández LE; Pérez C; Gill SS; Bravo A Toxicon; 2007 Apr; 49(5):597-600. PubMed ID: 17145072 [TBL] [Abstract][Full Text] [Related]
9. Microbiology. Translocation of anthrax toxin: lord of the rings. von Heijne G Science; 2005 Jul; 309(5735):709-10. PubMed ID: 16051774 [No Abstract] [Full Text] [Related]
10. Structure-function relationships of a membrane pore forming toxin revealed by reversion mutagenesis. Promdonkoy B; Ellar DJ Mol Membr Biol; 2005; 22(4):327-37. PubMed ID: 16154904 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of Cry19Aa mosquitocidal activity against Aedes aegypti by mutations in the putative loop regions of domain II. Abdullah MA; Dean DH Appl Environ Microbiol; 2004 Jun; 70(6):3769-71. PubMed ID: 15184189 [TBL] [Abstract][Full Text] [Related]
12. The PA14 domain, a conserved all-beta domain in bacterial toxins, enzymes, adhesins and signaling molecules. Rigden DJ; Mello LV; Galperin MY Trends Biochem Sci; 2004 Jul; 29(7):335-9. PubMed ID: 15236739 [No Abstract] [Full Text] [Related]
13. [Molecular mechanism of membrane pore formation with cholesterol binding cytolysin: streptolysin O and perfringolysin O]. Shimizu T; Hayashi H Tanpakushitsu Kakusan Koso; 2001 Mar; 46(4 Suppl):532-9. PubMed ID: 11268657 [No Abstract] [Full Text] [Related]
14. [Molecular mechanisms underlying the neuromuscular toxicity of Clostridium toxins]. Tashima Z; Alkalay M Harefuah; 1999 May; 136(10):794-9. PubMed ID: 10955116 [No Abstract] [Full Text] [Related]
15. Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax. Sellman BR; Mourez M; Collier RJ Science; 2001 Apr; 292(5517):695-7. PubMed ID: 11326092 [TBL] [Abstract][Full Text] [Related]
16. Interaction of bacterial toxin with leukocytes measured by flow cytometry. Paraje MG; Iribarren P; Albesa I Curr Microbiol; 2002 Sep; 45(3):171-4. PubMed ID: 12177737 [TBL] [Abstract][Full Text] [Related]
17. A dominant-negative therapy for anthrax. Leppla SH Nat Med; 2001 Jun; 7(6):659-60. PubMed ID: 11385497 [No Abstract] [Full Text] [Related]
18. Characterization of Bacillus subtilis clones surviving overproduction of Zeta, a pSM19035 plasmid-encoded toxin. Nowakowska B; Kern-Zdanowicz I; Zielenkiewicz U; Cegłowski P Acta Biochim Pol; 2005; 52(1):99-107. PubMed ID: 15827609 [TBL] [Abstract][Full Text] [Related]
19. Cell penetration of bacterial protein toxins. Montecucco C; Papini E Trends Microbiol; 1995 May; 3(5):165-7; discussion 167-8. PubMed ID: 7627453 [No Abstract] [Full Text] [Related]
20. Pore-forming toxins activate MAPK p38 by causing loss of cellular potassium. Kloft N; Busch T; Neukirch C; Weis S; Boukhallouk F; Bobkiewicz W; Cibis I; Bhakdi S; Husmann M Biochem Biophys Res Commun; 2009 Aug; 385(4):503-6. PubMed ID: 19497299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]